Blunted Heart Rate Response to Regadenoson Predicts Cardiovascular Risk Beyond Quantitative PET Myocardial Blood Flow. Barreto J, Vashist A, Gallegos Kattan C, Stendahl JC, et al. J Nucl Cardiol 2026 May 25:102766. doi: 10.1016/j.nuclcard.2026.102766.

Read + Share

Amedeo Smart

Independent Medical Education

Barreto J, Vashist A, Gallegos Kattan C, Stendahl JC, et al. Blunted Heart Rate Response to Regadenoson Predicts Cardiovascular Risk Beyond Quantitative PET Myocardial Blood Flow. J Nucl Cardiol 2026 May 25:102766. doi: 10.1016/j.nuclcard.2026.102766.
PMID: 42190937